Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Revenue | 19M | 12M | 2M | 4M |
| Research and development | 23M | 18M | 24M | 13M |
| Selling, general and administrative | 4M | 6M | 7M | 7M |
| Operating income | −8M | −12M | −29M | −16M |
| Net income | −6M | −11M | −27M | −15M |
| Earnings per share | −2.19 | −3.79 | −10.01 | −0.65 |
| Earnings per share, diluted | −2.19 | −3.79 | −10.01 | −0.65 |
| Weighted average shares | 3M | 3M | 3M | 23M |
| Weighted average shares, diluted | 3M | 3M | 3M | 23M |
| Metric | 18/08/2026 | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | 11M | 19M | 8M | 14M | 21M |
| Short-term investments | — | 13M | 4M | 20M | 9M |
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Operating cash flow | 322,000 | −14M | −18M | −9M |
| Depreciation and amortisation | 109,000 | 233,000 | 342,000 | 562,000 |
| Share-based compensation | 82,000 | 786,000 | 2M | 2M |
| Capital expenditure |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| Receivables | — | 2M | 4M | 377,000 | — | — |
| Current assets | — | 27M | 31M | 41M | — | — |
| Property, plant and equipment | — | 140,000 | 202,000 | 434,000 | — | — |
| Total assets | — | 30M | 36M | 45M | — | — |
| Current liabilities | — | 6M | 5M | 5M | — | — |
| Total liabilities | — | 7M | 7M | 7M | — | — |
| Equity | — | 23M | 29M | 39M | 42M | 56M |
| Shares outstanding | — | 3M | 3M | 28M | — | — |
| Shares issued | — | 3M | 3M | 28M | — | — |
| 47,000 |
| 2,000 |
| 134,000 |
| 171,000 |
| Investing cash flow | −9M | 27M | −10M | 2M |
| Financing cash flow | 6,000 | 0 | 22M | 15,000 |